Beijing-based Allink Biotherapeutics, a clinical-stage biotechnology firm, has successfully raised $42 million in a Series A funding round. The round saw participation from Lanchi Ventures as the lead investor, followed […]

On November 27th, Pony.ai, the Chinese autonomous driving firm, went public on the NASDAQ under the ticker “PONY,” marking its entry as a notable robotaxi company on the stock exchange. […]

Tuya Inc., a China-based cloud platform provider, revealed on Monday that it has finalized an agreement with 65 Equity Partners. Under the terms of the deal, 65 Equity Partners will […]

The Cyberport Venture Capital Forum 2024, a yearly event hosted by Cyberport, launched today in Hong Kong. Spanning two days, this year’s forum, titled “Innovation Challenger: Building New Venture Visions,” […]

The FBI is investigating Hone Capital, a Silicon Valley venture capital firm, over allegations that it may have shared sensitive information with China. The inquiry focuses on whether Hone’s connections […]

China’s clinical-stage biotech company, Duality Biotherapeutics, has filed for an initial public offering (IPO) on the Hong Kong Stock Exchange. The company, specializing in antibody-drug conjugates (ADCs), aims to raise […]

WeRide, a Chinese self-driving technology company, has postponed its initial public offering (IPO) in the United States, stating the need for additional time to finalize the required documents. The company […]

The early-stage VC firm Lanchi is extending its reach to Hong Kong, seeking to capitalize on the city’s financial prominence and abundant talent resources as reported by South China Morning […]

TymeBank, a South African digital bank backed by China’s Tencent Holdings, is raising $150 million (R2.8 billion) to enhance its growth as it gears up for an initial public offering […]

In January 2024, China saw the announcement of 251 venture capital (VC) funding deals, with a disclosed funding value of $2.6 billion, marking a decline of 8.4% in deal volume […]